Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)

CUSIP: 51654W101

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
11,280,432
Total 13F shares
1,335,871
Share change
+49,216
Total reported value
$4,902,351
Put/Call ratio
15%
Price per share
$3.67
Number of holders
31
Value change
+$118,888
Number of buys
12
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 51654W101?
CUSIP 51654W101 identifies LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
3.2%
363,720
$1,698,573 30 Jun 2024
13F
NewEdge Advisors, LLC
13F
Company
1.4%
157,124
$733,790 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.77%
86,347
$403,336 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.73%
81,800
$382,006 30 Jun 2024
13F
CM Management, LLC
13F
Company
0.71%
80,000
$373,600 30 Jun 2024
13F
DAVENPORT & Co LLC
13F
Company
0.57%
63,814
$298,011 30 Jun 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.53%
59,759
$279,075 30 Jun 2024
13F
BlackRock Finance, Inc.
13F
Company
0.35%
39,841
$186,057 30 Jun 2024
13F
Redmond Asset Management, LLC
13F
Company
0.35%
39,635
$185,095 30 Jun 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.31%
34,779
$162,418 30 Jun 2024
13F
HORIZON KINETICS ASSET MANAGEMENT LLC
13F
Company
0.26%
28,791
$134,454 30 Jun 2024
13F
Sigma Planning Corp
13F
Company
0.25%
28,400
$132,628 30 Jun 2024
13F
Bank of New York Mellon Corp
13F
Company
0.23%
26,482
$123,670 30 Jun 2024
13F
UBS Group AG
13F
Company
0.23%
25,500
$119,085 30 Jun 2024
13F
STATE STREET CORP
13F
Company
0.21%
23,652
$110,455 30 Jun 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.16%
18,413
$85,989 30 Jun 2024
13F
TOCQUEVILLE ASSET MANAGEMENT L.P.
13F
Company
0.15%
17,000
$79,390 30 Jun 2024
13F
Meridian Wealth Management, LLC
13F
Company
0.13%
14,945
$69,793 30 Jun 2024
13F
Jump Financial, LLC
13F
Company
0.11%
12,900
$60,243 30 Jun 2024
13F
NORTHERN TRUST CORP
13F
Company
0.11%
12,813
$59,837 30 Jun 2024
13F
Avantax Planning Partners, Inc.
13F
Company
0.1%
11,640
$54,359 30 Jun 2024
13F
Westside Investment Management, Inc.
13F
Company
0.1%
11,500
$53,705 30 Jun 2024
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.1%
10,896
$50,884 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.09%
10,135
$47,330 30 Jun 2024
13F
Fisher Asset Management, LLC
13F
Company
0.09%
10,000
$46,700 30 Jun 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.06%
7,058
$32,961 30 Jun 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.03%
3,200
$14,000 30 Jun 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
1,400
$7,000 30 Jun 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
1,339
$6,253 30 Jun 2024
13F
Indiana Trust & Investment Management Co
13F
Company
0.01%
750
$3,503 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
0.01%
600
$2,802 30 Jun 2024
13F
WOLFF WIESE MAGANA LLC
13F
Company
0.01%
600
$2,802 30 Jun 2024
13F
FMR LLC
13F
Company
0%
530
$2,474 30 Jun 2024
13F
RHUMBLINE ADVISERS
13F
Company
0%
208
$971 30 Jun 2024
13F
Cypress Capital, LLC
13F
Company
0%
200
$934 30 Jun 2024
13F
Allworth Financial LP
13F
Company
0%
100
$441 30 Jun 2024
13F
FEDERATED HERMES, INC.
13F
Company
0%
74
$346 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
69
$322 30 Jun 2024
13F
Qube Research & Technologies Ltd
13F
Company
0%
2
$10 30 Jun 2024
13F
Franklyn G. Prendergast
3/4/5
Director
class O/S missing
3,200
04 Nov 2021

Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q3 2024

As of 30 Sep 2024, Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,335,871 shares. The largest 10 holders included VANGUARD GROUP INC, CM Management, LLC, NewEdge Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, DAVENPORT & Co LLC, BlackRock, Inc., Redmond Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, and TWO SIGMA INVESTMENTS, LP. This page lists 31 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
39
Q3 2024 holders
31
Holder diff
-8
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .